Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
PH-762
product2 mentionslast seen Oct 13, 2026
An INTASYL compound that silences the PD-1 gene implicated in various forms of skin cancer, evaluated in Phase 1b trial for cutaneous squamous cell carcinoma, melanoma and Merkel cell carcinoma.
Relationships 9
- Phio Pharmaceuticals Corp.developsPH-76299% confidence2 sources
- PH-762applies tocutaneous squamous cell carcinoma95% confidence1 source
- PH-762applies toskin cancer treatment93% confidence1 source
- PH-762applies tocutaneous squamous cell carcinoma treatment90% confidence1 source
- PH-762applies toMerkel cell carcinoma treatment90% confidence1 source
- PH-762applies tomelanoma treatment90% confidence1 source
- PH-762depends onINTASYL siRNA gene-silencing platform90% confidence1 source
- PH-762composed ofINTASYL gene silencing technology85% confidence1 source
- PH-762applies toskin cancer80% confidence1 source
Relationship
Phio Pharmaceuticals Corp.developsPH-762
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- filingSEC EDGAROct 13, 2026Phio Pharmaceuticals Corp. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Phio's lead clinical development program is an INTASYL compound, PH-762
- filingSEC EDGARSep 14, 2026Phio Pharmaceuticals Corp. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Phio's lead clinical development program is an INTASYL compound, PH-762